AXA IM World Access Vehicle ICAV - AXA IM Maturity 2022 Fund F Distribution USD

Performance History30/04/2020
Growth of 1,000 (GBP) Advanced Graph
AXA IM World Access Vehicle ICAV - AXA IM Maturity 2022 Fund F Distribution USD
Fund--2.93.88.5-0.6
+/-Cat-----
+/-B’mrk-----
 
Key Stats
NAV
22/05/2020
 USD 97.57
Day Change 0.29%
Morningstar Category™ Fixed Term Bond
ISIN IE00BDBVWV76
Fund Size (Mil)
22/05/2020
 USD 474.23
Share Class Size (Mil)
22/05/2020
 USD 0.29
Max Initial Charge 2.00%
Ongoing Charge
19/02/2020
  0.70%
Investment Objective: AXA IM World Access Vehicle ICAV - AXA IM Maturity 2022 Fund F Distribution USD
The objective of the Fund is to seek to achieve an annualised return between 4% and 7%, gross of fees, in USD, to the Maturity Date, by investing primarily in corporate high yield debt securities. This annualised return is an objective and is not guaranteed.
Returns
Trailing Returns (GBP)22/05/2020
YTD4.87
3 Years Annualised5.24
5 Years Annualised-
10 Years Annualised-
12 Month Yield 4.93
Dividend Paying Frequency Annually
Management
Manager Name
Start Date
Carl Whitbeck
12/09/2016
Robert Houle
12/09/2016
Inception Date
26/09/2016
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
Not Benchmarked-
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeYes
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  AXA IM World Access Vehicle ICAV - AXA IM Maturity 2022 Fund F Distribution USD31/03/2020
Top 5 Holdings%
EMC Corporation 3.38%2.70
Fixed Income
Effective Maturity-
Effective Duration-
Morningstar Style Box®
Fixed Income Style
Asset Allocation
  % Long% Short% Net Assets
Stock0.000.000.00
Bond95.780.0095.78
Property0.000.000.00
Cash101.2997.074.22
Other0.000.000.00

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites